Notice Information
Notice Title
NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins
Notice Description
This market engagement relates to the NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins. The framework is anticipated to commence on 1 January 2025 for a period of 36 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Total maximum framework agreement including extension options will be no more than 48 months. The purpose of the PIN is to engage with the supply market on the procurement approach and to understand market and supplier capacities prior to the Invitation to Tender.
Lot Information
1-7
This market engagement relates to the NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins. The framework is anticipated to commence on 1 January 2025 for a period of 36 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Total maximum framework agreement including extension options will be no more than 48 months. The purpose of the PIN is to engage with the supply market on the procurement approach and to understand market and supplier capacities prior to the Invitation to Tender.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-044823
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/008035-2024
- Current Stage
- Planning
- All Stages
- Planning
Procurement Classification
- Notice Type
- Planning Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Not Specified
- Procurement Method Details
- Not specified
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33651520 - Immunoglobulins
Notice Value(s)
- Tender Value
- £1,400,000,000 £1B-£10B
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 13 Mar 20241 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- 27 May 2024Expired
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Planned
- Lots Status
- Planned
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND
- Contact Name
- Jennifer Tierney
- Contact Email
- jennifer.tierney@england.nhs.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- LEEDS
- Postcode
- LS2 7UE
- Post Town
- Leeds
- Country
- England
-
- Major Region (ITL 1)
- TLE Yorkshire and The Humber
- Basic Region (ITL 2)
- TLE4 West Yorkshire
- Small Region (ITL 3)
- TLE42 Leeds
- Delivery Location
- Not specified
-
- Local Authority
- Leeds
- Electoral Ward
- Little London & Woodhouse
- Westminster Constituency
- Leeds Central and Headingley
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-044823-2024-03-13T13:47:47Z",
"date": "2024-03-13T13:47:47Z",
"ocid": "ocds-h6vhtk-044823",
"description": "This market engagement relates to the NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins. The framework is anticipated to commence on 1 January 2025 for a period of 36 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Total maximum framework agreement including extension options will be no more than 48 months. <br/><br/>The purpose of the PIN is to engage with the supply market on the procurement approach and to understand market and supplier capacities prior to the Invitation to Tender. <br/><br/>The market engagement documents will be made available during March for unrestricted and full direct access, free of charge, at http://health.atamis.co.uk under project reference C228466.<br/><br/>Please be aware the NHSE principal address has changed to Wellington House 133-155 Waterloo Road London SE1 8UG",
"initiationType": "tender",
"tender": {
"id": "CM/PHS/23/5703",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins",
"status": "planned",
"classification": {
"scheme": "CPV",
"id": "33651520",
"description": "Immunoglobulins"
},
"mainProcurementCategory": "goods",
"description": "This market engagement relates to the NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins. The framework is anticipated to commence on 1 January 2025 for a period of 36 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Total maximum framework agreement including extension options will be no more than 48 months. The purpose of the PIN is to engage with the supply market on the procurement approach and to understand market and supplier capacities prior to the Invitation to Tender.",
"value": {
"amount": 1400000000,
"currency": "GBP"
},
"lots": [
{
"id": "1-7",
"title": "1-7",
"description": "This market engagement relates to the NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins. The framework is anticipated to commence on 1 January 2025 for a period of 36 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Total maximum framework agreement including extension options will be no more than 48 months. The purpose of the PIN is to engage with the supply market on the procurement approach and to understand market and supplier capacities prior to the Invitation to Tender.",
"status": "planned"
}
],
"items": [
{
"id": "1-7",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651520",
"description": "Immunoglobulins"
}
],
"deliveryAddresses": [
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Framework intended for use by the NHS in England, Northern Ireland, Scotland. The agreement may also be used by private sector contractors and agents working on behalf of the above."
},
"relatedLot": "1-7"
}
],
"communication": {
"futureNoticeDate": "2024-05-28T00:00:00+01:00",
"atypicalToolUrl": "https://health-family.force.com/s/Welcome"
},
"coveredBy": [
"GPA"
]
},
"parties": [
{
"id": "GB-FTS-67205",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "1st Floor, Quarry House, Quarry Hill",
"locality": "Leeds",
"region": "UKE",
"postalCode": "LS2 7UE",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Jennifer Tierney",
"email": "Jennifer.Tierney@england.nhs.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk//",
"buyerProfile": "https://www.england.nhs.uk//",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
}
],
"buyer": {
"id": "GB-FTS-67205",
"name": "NHS England"
},
"language": "en"
}